Treatment of autoimmune hemolytic anemia: real world data from a reference center in Mexico

BACKGROUND: Warm autoimmune hemolytic anemia (w-AIHA) is an uncommon disease with heterogeneous response to treatment. Steroids are the standard treatment at diagnosis, whereas rituximab has recently been recommended as the second-line therapy of choice. Our main objective was to document the respon...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Blood Res
Main Authors: Jaime-Pérez, José Carlos, Aguilar-Calderón, Patrizia, Salazar-Cavazos, Lorena, Gómez-De León, Andrés, Gómez-Almaguer, David
Format: Artigo
Jezik:Inglês
Izdano: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2019
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6614091/
https://ncbi.nlm.nih.gov/pubmed/31309092
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5045/br.2019.54.2.131
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki